DR. LINDSEY GRAHAM M.D.
Prescription History 1124265921
Internal Medicine - Hematology & Oncology in Fort Bliss, TX

Active since January 15, 2009PECOS Enrolled
18511 HIGHLANDER MEDICS ST, FORT BLISS, TX 79906 Get Directions

NPPES record last updated: August 14, 2025. Verified against the NPPES registry weekly; last sync: July 19, 2026.

Record update history: Aug 14, 2025, Dec 22, 2015, Oct 2, 2015 (3 updates tracked since 2015).

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. LINDSEY GRAHAM M.D., an active Hematology & Oncology specialist practicing in Fort Bliss, TX. Our medical registry currently tracks 1 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 12 documented patient claims. Among these therapy options, the most frequently utilized medication is Revlimid, which accounts for 12 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

1
Medication
12
Total Claims
12
30-Day Fills
Revlimid
Most Prescribed · 12 claims
View details
1 medication · 2023 Medicare Part D
Medicare Part D medications prescribed by DR. LINDSEY GRAHAM M.D. in 2023, with claim volumes, costs, and TX state comparisons
Medication Claims 30-Day Fills Days Supply Cost / Claim Utilization vs TX Avg
RevlimidLenalidomide1212.0336$19,422.97 Below Avg.

Utilization: claims vs the average TX prescriber

This provider
12
TX average
41.0

Averages are among TX prescribers of this medication. Utilization reflects practice size as well as clinical preference.

Cost per claim: this provider vs the TX average

This provider
$19,422.97
TX average
$18,173.54

Gross Part D cost per claim; not the patient's out-of-pocket price.

12.0
30-Day Fills
336
Days Supply

About Revlimid: Lenalidomide is used to treat various types of cancers. Show more ▾

It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication. A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA.

No medications match the current filters.
Above Avg. Typical Below Avg.= utilization vs the average TX prescriber of the same drug; volume reflects practice size as well as clinical preference.Green cost= below the TX average cost per claim.

About this data. The prescription history for DR. LINDSEY GRAHAM M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Hematology & Oncology prescribing approach at this Fort Bliss, TX practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among TX prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.